Novo Nordisk (NVO) is aimed at dominating the GLP-1 market News ad

Novo Nordisk (NVO) is aimed at dominating the GLP-1 market

 News ad

Novo Nordisk a/s. NYSE: NVO He announced that his GLP-1 drugs in chronic obesity, with Ozempic and Wegovy brands, are no longer in deficiency. This led to the fact that the United States Products and Medications Office took half -Glutid, an active ingredient in both, from a list of drug lack of drugs on February … Read more

How to build a portfolio resistant to inflation News ad

How to build a portfolio resistant to inflation

 News ad

Inflation, a gradual increase in prices over time, can undermine the cost of your investments if you are not prepared. As the cost of goods and services grows, the purchasing power of your money is reduced. This makes it decisive for planning and mitigating inflation, since you create wealth in the long run. The creation … Read more